文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Yttrium90-TARE with or without chemotherapy may improve survival in patients with locally advanced unresectable intrahepatic cholangiocarcinoma.

作者信息

Garita Esteban, Sarwar Ammar, Tahir Mohid, Sucre Santiago, Whaley Juan J Juarez-Vignon, Peters Mary L, Bullock Andrea J

机构信息

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA.

出版信息

Discov Oncol. 2025 Jul 22;16(1):1386. doi: 10.1007/s12672-025-03242-3.

DOI:10.1007/s12672-025-03242-3
PMID:40694260
Abstract
摘要

相似文献

[1]
Yttrium90-TARE with or without chemotherapy may improve survival in patients with locally advanced unresectable intrahepatic cholangiocarcinoma.

Discov Oncol. 2025-7-22

[2]
Liver Transplantation for Intrahepatic Cholangiocarcinoma After Chemotherapy and Radioembolization: An Intention-To-Treat Study.

Transpl Int. 2024

[3]
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?

World J Hepatol. 2023-12-27

[4]
Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma.

Clin Transl Radiat Oncol. 2019-7-26

[5]
Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation.

Curr Oncol. 2025-5-22

[6]
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.

J Natl Cancer Inst. 2025-2-1

[7]
Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.

PLoS One. 2017-9-21

[8]
First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma.

J Cancer Res Clin Oncol. 2024-6-18

[9]
Hepatic Artery Infusion Chemotherapy Compared to Transarterial Radioembolization For Unresectable Colorectal Liver Metastases.

Ann Surg. 2025-7-25

[10]
Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.

Abdom Radiol (NY). 2023-7

本文引用的文献

[1]
Subcutaneous adipose tissue radiodensity as a predictor of poor prognosis in advanced biliary tract cancer.

J Hepatobiliary Pancreat Sci. 2025-3

[2]
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy.

Cancer Diagn Progn. 2025-1-3

[3]
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2024-10-31

[4]
Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.

Cardiovasc Intervent Radiol. 2024-3

[5]
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer.

NEJM Evid. 2022-8

[6]
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.

Hepatology. 2024-1-1

[7]
The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Front Mol Biosci. 2022-12-2

[8]
Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.

J Vasc Interv Radiol. 2023-4

[9]
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians.

CA Cancer J Clin. 2023-3

[10]
Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study.

Sci Rep. 2021-2-17

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索